AlzChem Group AG (ALZCF) Stock

About AlzChem Group AG

AlzChem Group AG, an entity operating with its subsidiaries, is a globally active chemical company. It focuses on the development, manufacturing, and distribution of a wide array of chemical products across Germany, the European Union, the broader European continent, Asia, the NAFTA region, and other international markets. The company's operations are divided into three core segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. Its product portfolio is extensive, featuring human dietary supplements such as Creapure and Alipure, alongside LIVADUR-branded creatine supplements. For animal nutrition, it provides guanidinoacetic acid under the Creamino brand. The pharmaceutical sector is served by its Bioselect products. Industrially, AlzChem supplies DYHARD curing agents and accelerators, essential for applications in adhesives, powder coatings, printed circuit boards, and composites. It also manufactures SILZOT silicon nitride, a material used in ceramics, electronics, and solar technology. Further offerings include a variety of fine and specialty chemicals based on compounds like calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, nitroguanidine, as well as aromatic and aliphatic nitriles. Specific agricultural products include PERLKA calcium cyanamide, ALZOGUR germicide for pig pens, Dormex and Sitofex plant growth regulators, and BREAK-THRU plant protection additives. The company also provides products vital for industrial processes such as hot metal desulfurization and secondary metallurgy, in addition to technical gases. Beyond manufacturing, AlzChem Group AG is involved in managing chemical park operations, delivering administrative support, and supplying various infrastructure services. The company was founded in 1908 and is headquartered in Trostberg, Germany.

AlzChem Group AG is headquartered in DE.

AlzChem Group AG (ALZCF) stock trades at $197.50 with a market capitalization of $2.00B. The stock is valued at a price-to-earnings (P/E) ratio of 26.94, price-to-book of 6.53, price-to-sales of 3.19. Over the past 52 weeks the stock has ranged between $152.50 and $223.25, and currently trades 11.5% below its 52-week high. It pays a dividend yielding 1.25%.

On profitability, AlzChem Group AG generates a return on equity (ROE) of 27.13% — well above the market average, a sign of a high-quality business, return on capital employed of 17.00%, an operating margin of 15.47%, a net profit margin of 11.80%.

Official website: www.alzchem.com